跳至主要内容
临床试验/CTRI/2016/11/007510
CTRI/2016/11/007510已完成不适用

A clinical study of vardhamana pippali kalpa in the management of amavata vis-a-vis rheumatoid arthritis

J S ayurveda college1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年2月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
effect of the vardhamana pippali kalpa in the patients of amavata

研究概览

简要总结

Clinical evaluation of the effectiveness of vardhaman pippali kalpa in the management of amavata is the main object of the study. Patients will be selected from the P D Patel ayurveda hospital, Nadiad, after the confirmation of the diagnosis of amavata with the help of classical signs and symptoms. they will be treated with Powder of pippali (Piper longum Linn.) in vardhmana krama,i.e. starting the dose from 1 gm on the first day, twice a day with hot water will given. It will be increased by 1 gm daily up to a maximum dose of 5 gm twice a day. The maximum dose, i.e.5 gm will be given for 5 days and then it will be tapered by 1 gm daily to a dose of 1 gm twice a day. Patients will be kept on mudgayuá¹£a. Total duration of the treatment will be of 13 days. Assessment will be done with the help of changes in gradation of the signs and symptoms of amavata, ESR, DAS-28 scale, disability  index (the indian health assessment questionnaire). Result will be analysed with student t test.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 1.Presence of sandhiÅ›ula (pain in joints), sandhijÄdyatÄ (stiffness in joints), sandhisotha (swelling in joints), restriction of movement.
  • 2.Presence of any six out of the following ten classification criteria and European league against rheumatism (EULAR).

排除标准

  • 1.Patients who have developed complications of rheumatoid arthritis e.g. Severe deformity of jointsones, pleura-pericardial disease, or else.
  • 2.Association of a joint disease of other origin.
  • 3.Patients having HbA1c above 7.5 of diabetes mellitus.
  • 4.Patients on prolonged medication with immunosuppressive e.g. corticosteroids any other drugs within last 6 months that may have an influence on the outcome of the study.
  • 5.Pregnant/lactating women.

结局指标

主要结局

effect of the vardhamana pippali kalpa in the patients of amavata

时间窗: Grade score of signs and symptoms

次要结局

未报告次要终点

研究者

发起方
J S ayurveda college
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验

Ayurvedic management of amavata (Rheumatoid... | 临床试验